Home

Tourist Anordnung von entlang xten sequence Kontrolle erlangen Hampelmann Daumen

Introduction to XTEN v1
Introduction to XTEN v1

Extension of in vivo half-life of biologically active molecules by XTEN  protein polymers - ScienceDirect
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect

Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1)  (RTW1352)
Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1) (RTW1352)

Team:NUS Singapore-Sci/Editor Overview - 2018.igem.org
Team:NUS Singapore-Sci/Editor Overview - 2018.igem.org

Addgene: pCAG-NLS(SV40)x2-rAPOBEC1-gs-XTEN-gs-hdLbCas12a(D832A)-gs-UGI-NLS(SV40)(LbBE1.4)  (RTW1293) Sequences
Addgene: pCAG-NLS(SV40)x2-rAPOBEC1-gs-XTEN-gs-hdLbCas12a(D832A)-gs-UGI-NLS(SV40)(LbBE1.4) (RTW1293) Sequences

Long-circulating XTEN864-annexin A5 fusion protein for  phosphatidylserine-related therapeutic applications | SpringerLink
Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications | SpringerLink

WO2013130684A1 - Xten-folate conjugate compositions and methods of making  same - Google Patents
WO2013130684A1 - Xten-folate conjugate compositions and methods of making same - Google Patents

Evaluation of hyPE2 linker variants. a Detailed information about the... |  Download Scientific Diagram
Evaluation of hyPE2 linker variants. a Detailed information about the... | Download Scientific Diagram

Extension of in vivo half-life of biologically active molecules by XTEN  protein polymers - ScienceDirect
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect

Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA
Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA

Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate  on-target, off-tumor toxicity for immunotherapy in solid tumors | Nature  Cancer
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors | Nature Cancer

XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating  Protein-Based Imaging Probes as Recombinant Alternative to
XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to

Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA
Addgene: pCAG_NLS-Cas9-XTEN-Ec73RT-NLS_pA_pCMV_BFP_pA

XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating  Protein-Based Imaging Probes as Recombinant Alternative to PEGylation |  Journal of Nuclear Medicine
XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to PEGylation | Journal of Nuclear Medicine

Frontiers | CRISPR-Assisted Multiplex Base Editing System in Pseudomonas  putida KT2440
Frontiers | CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440

Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life  and Enhanced Solubility | Bioconjugate Chemistry
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility | Bioconjugate Chemistry

Figure C. Schematic representation of XTEN-Killin DNA constructs.... |  Download Scientific Diagram
Figure C. Schematic representation of XTEN-Killin DNA constructs.... | Download Scientific Diagram

XTEN Conjugation v1
XTEN Conjugation v1

Expanding the genome-targeting scope and the site selectivity of  high-precision base editors | Nature Communications
Expanding the genome-targeting scope and the site selectivity of high-precision base editors | Nature Communications

Targeted Base Editing Systems Are Available for Plants: Trends in Plant  Science
Targeted Base Editing Systems Are Available for Plants: Trends in Plant Science

WO2013130684A1 - Xten-folate conjugate compositions and methods of making  same - Google Patents
WO2013130684A1 - Xten-folate conjugate compositions and methods of making same - Google Patents

XTEN as Biological Alternative to PEGylation Allows Complete Expression of  a Protease-Activatable Killin-Based Cytostatic | PLOS ONE
XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic | PLOS ONE

Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life  and Enhanced Solubility | Bioconjugate Chemistry
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility | Bioconjugate Chemistry

RCSB PDB - 7KWO: rFVIIIFc-VWF-XTEN (BIVV001)
RCSB PDB - 7KWO: rFVIIIFc-VWF-XTEN (BIVV001)

Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1)  (RTW1352) Sequences
Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1) (RTW1352) Sequences

T Cell Engagers | XPAT™ Platform | Amunix Pharmaceuticals
T Cell Engagers | XPAT™ Platform | Amunix Pharmaceuticals

Generation of highly diverse peptide library by linear-double-stranded DNA  based AND gate genetic circuit in mammalian cells | bioRxiv
Generation of highly diverse peptide library by linear-double-stranded DNA based AND gate genetic circuit in mammalian cells | bioRxiv

WO2017024060A1 - Factor ix fusion proteins and methods of making and using  same - Google Patents
WO2017024060A1 - Factor ix fusion proteins and methods of making and using same - Google Patents